Profile
Substance use treatment; Outpatient; Outpatient methadone/buprenorphine or naltrexone treatment; Buprenorphine used in Treatment; Naltrexone used in Treatment; This facility administers/prescribes medication for alcohol use disorder; No formal relationship with prescribing entity; Buprenorphine maintenance; Prescribes buprenorphine; Prescribes naltrexone; Relapse prevention with naltrexone; Acamprosate (CampralĀ®); Disulfiram; Buprenorphine with naloxone; Buprenorphine without naloxone; Naltrexone (oral); Naltrexone (extended-release, injectable); Clonidine; Medication for mental disorders; Nicotine replacement; Non-nicotine smoking/tobacco cessation; Telemedicine/telehealth therapy; Private non-profit organization; State Substance use treatment agency; State mental health department; Commission on Accreditation of Rehabilitation Facilities (CARF); Federal, or any government funding for substance use treatment programs; Medicare; Medicaid; Federal military insurance (e.g., TRICARE); Private health insurance; Cash or self-payment; State-financed health insurance plan other than Medicaid; Comprehensive mental health assessment; Screening for tobacco use; Screening for substance use; Screening for mental disorders; Drug or alcohol urine screening; Metabolic syndrome monitoring; Aftercare/continuing care; Discharge Planning; Substance use disorder education; Smoking/vaping/tobacco cessation counseling; Smoking not permitted; Children/adolescents; Female; Male; Vaping not permitted; Mental health services